| 2023-11-06 | +42.0% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-05-03 | +36.0% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2024-10-28 | -29.8% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-02-23 | +23.5% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2024-04-30 | +22.8% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-11-03 | +20.3% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2023-02-22 | +19.8% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2024-12-02 | -17.8% | legal | SEC EDGAR | TMDX 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-05-08 | +15.8% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-07-30 | +14.0% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2021-05-04 | -12.0% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-26 | +11.2% | news | Yahoo Finance | Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance |
| 2023-11-13 | +11.1% | legal | SEC EDGAR | TMDX 8-K: 1.01, 2.01 (SEC Filing) |
| 2021-11-09 | -10.9% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2026-03-05 | -10.4% | news | Investor's Business Daily | Medical Stock Nears Buy Point Amid Liver Transplant Demand Surge - Investor's Business Daily |
| 2023-05-09 | +10.3% | legal | SEC EDGAR | TMDX 8-K: 1.01 and (SEC Filing) |
| 2026-02-27 | +9.7% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-08-08 | -9.5% | legal | SEC EDGAR | TMDX 8-K: 8.01 and (SEC Filing) |
| 2024-07-31 | +9.3% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-11-24 | +9.1% | analyst | Investor's Business Daily | TransMedics Group Joins Rank Of Stocks With RS Ratings Over 90 - Investor's Business Daily |
| 2021-08-05 | +8.8% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-06-18 | -8.7% | news | Yahoo Finance | TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care - Yahoo Finance |
| 2025-10-31 | -8.7% | news | Seeking Alpha | TransMedics: Growth Tailwinds Should Provide Upside In 2026 |
| 2025-10-31 | -8.7% | news | Yahoo Finance | Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance |
| 2025-10-31 | -8.7% | news | Seeking Alpha | TransMedics: Growth Tailwinds Should Provide Upside In 2026 (NASDAQ:TMDX) - Seeking Alpha |
| 2023-08-03 | -8.1% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-09-03 | -8.1% | executive | Seeking Alpha | TransMedics: Just Like The CEO, I'm Buying |
| 2025-09-03 | -8.1% | executive | Seeking Alpha | TransMedics: Just Like The CEO, I'm Buying (NASDAQ:TMDX) - Seeking Alpha |
| 2024-09-11 | +8.0% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2025-10-23 | +7.8% | analyst | Seeking Alpha | TransMedics upgraded at Needham on strong US sales |
| 2025-01-14 | -7.6% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2025-10-22 | +7.2% | earnings | Yahoo Finance | TransMedics (TMDX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance |
| 2024-02-26 | +6.9% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-08-01 | -6.7% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2026-04-15 | -6.7% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Stryker (SYK) and Genmab (GMAB) - The Globe and Mail |
| 2023-09-22 | -6.5% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2025-10-09 | -6.1% | news | Yahoo Finance | There's Been No Shortage Of Growth Recently For TransMedics Group's (NASDAQ:TMDX) Returns On Capital - Yahoo Finance |
| 2026-01-13 | +6.1% | news | Seeking Alpha | TransMedics: Strong Growth And A Better Setup |
| 2026-01-13 | +6.1% | news | Seeking Alpha | TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-01-13 | +6.1% | news | Seeking Alpha | TransMedics Group, Inc. (TMDX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow |
| 2026-01-13 | +6.1% | news | Seeking Alpha | TransMedics: Strong Growth And A Better Setup (NASDAQ:TMDX) - Seeking Alpha |
| 2025-10-29 | +5.7% | earnings | Seeking Alpha | TransMedics Group GAAP EPS of $0.66 beats by $0.31, revenue of $143.8M misses by $0.96M |
| 2025-10-29 | +5.7% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-10-29 | +5.7% | earnings | Yahoo Finance | TransMedics (TMDX) Beats Q3 Earnings Estimates - Yahoo Finance |
| 2026-03-27 | -5.7% | news | Stock Titan | [SCHEDULE 13G/A] TransMedics Group, Inc. Amended Passive Investment Disclosure - Stock Titan |
| 2026-03-11 | -5.6% | earnings | Yahoo Finance | Analysts Raise TransMedics Group, Inc. (TMDX) Price Targets After Q4 Results - Yahoo Finance |
| 2026-03-04 | -5.5% | executive | Investing.com | TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com |
| 2023-05-01 | -5.5% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2022-07-29 | +5.2% | legal | SEC EDGAR | TMDX 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2025-09-16 | +5.1% | news | Seeking Alpha | TransMedics: Upcoming Trials Are Critical |
| 2025-08-02 | +5.1% | news | Yahoo Finance | TransMedics Group, Inc. (TMDX): A Bull Case Theory - Yahoo Finance |
| 2026-03-25 | -4.9% | news | Zacks | Reasons to Retain TransMedics Stock in Your Portfolio for Now |
| 2026-03-25 | -4.9% | news | Yahoo Finance | Reasons to Retain TransMedics Stock in Your Portfolio for Now - Yahoo Finance |
| 2026-03-25 | -4.9% | news | simplywall.st | Is It Time To Revisit TransMedics Group (TMDX) After The Recent Share Price Pullback - simplywall.st |
| 2023-09-05 | -4.9% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2025-09-24 | -4.7% | news | Yahoo Finance | Here's Why TransMedics (TMDX) is a Strong Growth Stock - Yahoo Finance |
| 2025-12-09 | -4.5% | news | Yahoo Finance | Even though TransMedics Group (NASDAQ:TMDX) has lost US$472m market cap in last 7 days, shareholders are still up 788% over 5 years - Yahoo Finance |
| 2026-01-21 | -4.4% | news | ChartMill | TransMedics Group Inc (TMDX) Fits the Minervini Trend Template with Strong-Growth Momentum - ChartMill |
| 2026-01-21 | -4.4% | legal | Investing.com | TransMedics stock falls after Bridge to Life wins FDA clearance for liver device - Investing.com |
| 2025-02-21 | +4.4% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-01-12 | +4.2% | legal | SEC EDGAR | TMDX 8-K: 1.01, 8.01 (SEC Filing) |
| 2023-06-29 | -3.8% | legal | SEC EDGAR | TMDX 8-K: 1.01 and (SEC Filing) |
| 2024-01-02 | -3.8% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-02-24 | -3.7% | earnings | Seeking Alpha | TransMedics Group GAAP EPS of $2.62 beats by $2.26, revenue of $160.8M beats by $5.52M |
| 2026-02-24 | -3.7% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2026-02-24 | -3.7% | earnings | Yahoo Finance | TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates - Yahoo Finance |
| 2026-02-24 | -3.7% | news | Stock Titan | Organ transplant tech firm TransMedics tops $600M in 2025 sales - Stock Titan |
| 2026-04-23 | -3.6% | news | PR Newswire | TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting |
| 2026-04-23 | -3.6% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX) and Boston Scientific (BSX) - The Globe and Mail |
| 2026-04-23 | -3.6% | executive | Stock Titan | TransMedics puts new organ-cooling device into heart, lung trial plans - Stock Titan |
| 2025-09-08 | +3.6% | news | Seeking Alpha | TransMedics Group, Inc. (TMDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2025-09-08 | +3.6% | news | Yahoo Finance | Why TransMedics (TMDX) is a Top Growth Stock for the Long-Term - Yahoo Finance |
| 2026-04-03 | +3.6% | news | Seeking Alpha | Most and least shorted mid-to mega-cap healthcare stocks in March |
| 2025-02-27 | +3.5% | legal | SEC EDGAR | TMDX 8-K: 2.02 and (SEC Filing) |
| 2025-12-24 | -3.5% | news | Seeking Alpha | TransMedics Group: I Estimate A Large Upside By The End Of 2028 |
| 2025-12-24 | -3.5% | news | Seeking Alpha | TransMedics Stock: I Estimate An Upside Of Nearly 150% By The End Of 2028 (NASDAQ:TMDX) - Seeking Alpha |
| 2025-12-24 | -3.5% | news | Stock Titan | New TransMedics hires get stock options and units with long vesting - Stock Titan |
| 2026-03-06 | -3.3% | earnings | ChartMill | TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Earnings Momentum with Bullish Technical Setup - ChartMill |
| 2026-04-22 | +3.3% | news | GuruFocus | A Look at TransMedics Group Inc (TMDX) After 5.3% Gain -- GF Val - GuruFocus |
| 2025-09-04 | -3.3% | news | Seeking Alpha | TransMedics initiated with Hold at Stifel on mixed survey results |
| 2026-03-08 | +3.1% | news | Yahoo Finance | Assessing TransMedics Group (TMDX) Valuation After Recent Short Term Share Price Weakness - Yahoo Finance |
| 2026-03-08 | +3.1% | news | The Motley Fool | TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool |
| 2026-03-07 | +3.1% | news | Trefis | TransMedics Stock (-7.5%): Stagflation Fears and Insider Sales Fuel Sell-Off - Trefis |
| 2026-03-07 | +3.1% | news | Investing.com | Lovell, TransMedics director, sells $178k in TMDX stock - Investing.com |
| 2026-03-07 | +3.1% | news | Investing.com | Weill David sells TransMedics (TMDX) shares worth $524,294 - Investing.com |
| 2025-08-29 | -3.1% | earnings | Yahoo Finance | Why Is TransMedics (TMDX) Down 1.9% Since Last Earnings Report? - Yahoo Finance |
| 2023-05-11 | -3.0% | legal | SEC EDGAR | TMDX 8-K: 1.01, 2.03, 3.02 (SEC Filing) |
| 2025-07-15 | -3.0% | earnings | Yahoo Finance | Headwaters Capital Management Sold Transmedics (TMDX) After a Strong Q1 Report - Yahoo Finance |
| 2026-02-23 | +2.9% | earnings | Seeking Alpha | TransMedics Group Q4 2025 Earnings Preview |
| 2026-02-23 | +2.9% | earnings | GuruFocus | TransMedics Group (TMDX) Q4 Earnings Preview: Key Expectations - GuruFocus |
| 2026-02-09 | +2.9% | legal | Stock Titan | TransMedics' 650+ patient heart transplant trial gets full FDA go-ahead - Stock Titan |
| 2026-02-16 | +2.9% | news | ChartMill | TransMedics Group Inc (NASDAQ:TMDX) Screened as a High-Momentum Growth Stock - ChartMill |
| 2026-04-10 | +2.9% | news | Stock Titan | TransMedics (NASDAQ: TMDX) details 2025 surge, executive pay and proxy votes - Stock Titan |
| 2026-04-10 | +2.9% | news | GuruFocus | A Look at TransMedics Group Inc (TMDX) After 4.4% Gain -- GF Val - GuruFocus |
| 2026-02-04 | -2.8% | legal | SEC EDGAR | TMDX 8-K: 5.02 (SEC Filing) |
| 2026-02-04 | -2.8% | news | ChartMill | TransMedics Group Inc (NASDAQ:TMDX): A GARP Stock with Strong Growth at a Fair Price - ChartMill |
| 2026-02-04 | -2.8% | news | TIKR.com | Up 95% In Last 12 Months, Can TransMedics Stock Keep Climbing In 2026? - TIKR.com |
| 2026-03-02 | +2.7% | news | DirectorsTalk Interviews | TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews |
| 2026-04-17 | +2.7% | earnings | MarketBeat | TransMedics Group (NASDAQ:TMDX) Stock Price Up 8.5% - Here's What Happened - MarketBeat |
| 2026-04-17 | +2.7% | analyst | GuruFocus | Oppenheimer Raises Price Target for TransMedics Group (TMDX) to - GuruFocus |
| 2025-09-19 | +2.7% | news | Yahoo Finance | Why TransMedics (TMDX) is a Top Momentum Stock for the Long-Term - Yahoo Finance |
| 2025-09-19 | +2.7% | news | Yahoo Finance | TransMedics Group, Inc. (TMDX): A Bull Case Theory - Yahoo Finance |
| 2026-03-22 | -2.6% | executive | MarketBeat | TransMedics Group Conference: CEO Outlines NOP Expansion, ENHANCE Trial Plans and Kidney Push |
| 2025-12-23 | -2.6% | legal | Seeking Alpha | TransMedics: A Stagnant Monopoly Facing Regulatory Pressure |
| 2025-12-23 | -2.6% | legal | Seeking Alpha | TransMedics: A Stagnant Monopoly Facing Regulatory Pressure (NASDAQ:TMDX) - Seeking Alpha |
| 2026-02-25 | -2.6% | earnings | Seeking Alpha | TransMedics Group, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-25 | -2.6% | earnings | Seeking Alpha | TransMedics outlines 20–25% 2026 revenue growth target while advancing OCS programs and European expansion |
| 2026-02-25 | -2.6% | earnings | Seeking Alpha | TransMedics Group, Inc. (TMDX) Q4 2025 Earnings Call Transcript |
| 2026-02-25 | -2.6% | earnings | Finviz | TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates - Finviz |
| 2026-02-25 | -2.6% | earnings | Investing.com | Needham raises TransMedics stock price target to $174 on beat - Investing.com |
| 2026-01-25 | +2.5% | news | Stock Traders Daily | Precision Trading with Transmedics Group Inc. (TMDX) Risk Zones - Stock Traders Daily |
| 2026-03-26 | -2.3% | news | Simply Wall St. | TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform Ambitions |
| 2026-03-26 | -2.3% | earnings | Zacks | TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound? |
| 2026-03-26 | -2.3% | earnings | Yahoo Finance | TransMedics (TMDX) Down 20.3% Since Last Earnings Report: Can It Rebound? - Yahoo Finance |
| 2026-03-26 | -2.3% | news | Yahoo Finance | TransMedics Group (TMDX) Is Down 7.1% After Expanding Its National OCS Transplant Platform Ambitions - Yahoo Finance |
| 2024-12-09 | +1.9% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2021-08-09 | -1.8% | legal | SEC EDGAR | TMDX 8-K: 5.02 and (SEC Filing) |
| 2026-04-07 | +1.8% | news | MT Newswires | TransMedics Facing 'Misplaced' Concerns Over Increasing Jet Fuel Prices, Oppenheimer Says |
| 2026-04-07 | +1.8% | analyst | Investing.com | Oppenheimer reiterates TransMedics stock rating amid fuel costs - Investing.com |
| 2026-04-07 | +1.8% | legal | Stock Titan | TMDX SEC Filings - Transmedics Group 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2026-04-16 | -1.7% | analyst | Motley Fool | 2 Healthcare Stocks That Could Outperform the Market Over the Next Decade |
| 2026-04-16 | -1.7% | analyst | The Motley Fool | 2 Healthcare Stocks That Could Outperform the Market Over the Next Decade - The Motley Fool |
| 2026-04-16 | -1.7% | earnings | MarketBeat | TransMedics Group (NASDAQ:TMDX) Trading Down 5% - Here's Why - MarketBeat |
| 2026-04-16 | -1.7% | news | GuruFocus | TransMedics Group Inc (TMDX) Shares Fall 6.0% -- What GF Score o - GuruFocus |
| 2026-02-02 | +1.7% | news | ChartMill | TransMedics Group Inc (NASDAQ:TMDX) Shows Strong Growth Momentum and Technical Setup - ChartMill |
| 2025-09-09 | +1.6% | news | Yahoo Finance | Here’s Why Wall Street is Bullish on TransMedics Group (TMDX) - Yahoo Finance |
| 2024-07-02 | -1.6% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-04-12 | -1.5% | news | simplywall.st | A Look At TransMedics Group (TMDX) Valuation After Positive Cash Flow And Organ Care System Expansion - simplywall.st |
| 2026-02-03 | -1.4% | news | Seeking Alpha | TransMedics: Italian NOP Program Reinforces Huge International Opportunity |
| 2026-02-03 | -1.4% | news | Seeking Alpha | TransMedics: Italian NOP Program Reinforces Huge International Opportunity (NASDAQ:TMDX) - Seeking Alpha |
| 2025-09-22 | -1.4% | news | Seeking Alpha | TransMedics: I'm More Bullish Than Ever |
| 2025-11-20 | -1.4% | news | Yahoo Finance | TransMedics (TMDX) Just Overtook the 20-Day Moving Average - Yahoo Finance |
| 2026-02-21 | +1.3% | news | ChartMill | TransMedics Group Inc (NASDAQ:TMDX) Presents a Strong Growth and Technical Breakout Opportunity - ChartMill |
| 2025-10-30 | -1.3% | earnings | Seeking Alpha | TransMedics: Q3 Results Disappointed, As Expected (Rating Upgrade) |
| 2025-10-30 | -1.3% | earnings | Seeking Alpha | TransMedics Group, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-10-30 | -1.3% | earnings | Seeking Alpha | TransMedics targets up to $605M 2025 revenue as international expansion accelerates |
| 2025-10-30 | -1.3% | earnings | Seeking Alpha | TransMedics Group, Inc. (TMDX) Q3 2025 Earnings Call Transcript |
| 2025-10-30 | -1.3% | earnings | Yahoo Finance | TransMedics Group (TMDX) Is Up 12.4% After Strong Q3 Earnings and Mercedes-Benz Partnership Announcement - Yahoo Finance |
| 2025-10-30 | -1.3% | earnings | Yahoo Finance | TMDX Stock Falls Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y - Yahoo Finance |
| 2025-10-30 | -1.3% | earnings | Yahoo Finance | TransMedics (TMDX) Net Profit Margin Doubles, Reinforcing Bullish Momentum Narratives - Yahoo Finance |
| 2023-12-19 | +1.3% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-02-28 | +1.1% | news | The Motley Fool | Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - The Motley Fool |
| 2026-02-12 | -1.1% | news | Yahoo Finance | Is Now An Opportune Moment To Examine TransMedics Group, Inc. (NASDAQ:TMDX)? - Yahoo Finance |
| 2025-10-28 | +1.1% | earnings | Seeking Alpha | TransMedics Group Q3 2025 Earnings Preview |
| 2025-10-28 | +1.1% | earnings | Investor's Business Daily | Heart Transplant Play Nears Buy Point. Analysts See Earnings Surging Again. - Investor's Business Daily |
| 2025-10-20 | +1.1% | earnings | Seeking Alpha | TransMedics Group: Guidance Up, Durability In Question |
| 2025-10-20 | +1.1% | earnings | Seeking Alpha | TransMedics Group: Guidance Up, Durability In Question (NASDAQ:TMDX) - Seeking Alpha |
| 2024-07-29 | -1.0% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-04-21 | +1.0% | news | PR Newswire | TransMedics to Report First Quarter 2026 Financial Results on May 5, 2026 |
| 2026-04-21 | +1.0% | news | Stock Titan | TransMedics will discuss first-quarter results after market close May 5 - Stock Titan |
| 2025-12-15 | -1.0% | news | simplywall.st | Is TransMedics Group, Inc.'s (NASDAQ:TMDX) ROE Of 26% Impressive? - simplywall.st |
| 2026-02-18 | -0.9% | legal | Yahoo Finance | A Look At TransMedics Group (TMDX) Valuation After Full FDA Approval For Next Generation OCS Heart Trial - Yahoo Finance |
| 2026-02-18 | -0.9% | legal | Yahoo Finance | The Bull Case For TransMedics Group (TMDX) Could Change Following Full FDA Approval Of ENHANCE Heart Trial - Yahoo Finance |
| 2023-02-24 | +0.9% | legal | SEC EDGAR | TMDX 8-K: 5.02 and (SEC Filing) |
| 2026-01-14 | +0.9% | news | ChartMill | TransMedics Group Inc (NASDAQ:TMDX): A GARP Investment Case Study - ChartMill |
| 2026-01-14 | +0.9% | news | TradingView | Reasons to Retain TransMedics Stock in Your Portfolio for Now - TradingView |
| 2025-12-08 | -0.9% | news | Quiver Quantitative | TransMedics Group Stock (TMDX) Opinions on Recent Insider Sales | TMDX Stock News - Quiver Quantitative |
| 2025-12-08 | -0.9% | news | Finviz | TransMedics Group, Inc. (TMDX): A Bull Case Theory - Finviz |
| 2026-01-08 | -0.8% | news | Yahoo Finance | Is Now The Time To Put TransMedics Group (NASDAQ:TMDX) On Your Watchlist? - Yahoo Finance |
| 2024-02-06 | +0.7% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-01-28 | +0.6% | news | Yahoo Finance | Is It Too Late To Consider TransMedics Group (TMDX) After Its 106% One Year Rally? - Yahoo Finance |
| 2026-01-28 | +0.6% | news | Investor's Business Daily | This Medical Technology Specialist Needs A Push To Break Out - Investor's Business Daily |
| 2024-03-12 | -0.5% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2023-09-12 | -0.5% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2025-10-06 | -0.4% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-04-14 | +0.4% | news | Simply Wall St. | Does TransMedics Group's (TMDX) Cash Flow Turn and Fleet Expansion Reshape Its Capital Allocation Story? |
| 2026-04-14 | +0.4% | news | Yahoo Finance | Does TransMedics Group's (TMDX) Cash Flow Turn and Fleet Expansion Reshape Its Capital Allocation Story? - Yahoo Finance |
| 2026-04-14 | +0.4% | news | simplywall.st | Why TransMedics (TMDX) Is Up 8.2% After Record OCS Volumes And First Full Year Cash Flow - simplywall.st |
| 2026-04-14 | +0.4% | earnings | MarketBeat | TransMedics Group, Inc. $TMDX Position Lifted by Baillie Gifford & Co. - MarketBeat |
| 2025-06-24 | -0.3% | news | Yahoo Finance | Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label Update - Yahoo Finance |
| 2026-03-16 | -0.3% | news | Seeking Alpha | TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven |
| 2026-03-16 | -0.3% | news | Seeking Alpha | TransMedics: Rapidly Scaling Business Nears Free Cash Flow Breakeven (NASDAQ:TMDX) - Seeking Alpha |
| 2026-03-16 | -0.3% | analyst | Investing.com | TD Cowen reiterates TransMedics stock Buy rating on liver approval - Investing.com |
| 2026-03-09 | +0.2% | analyst | Seeking Alpha | TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) |
| 2026-03-09 | +0.2% | news | Seeking Alpha | TransMedics: Numb Reaction To Extraordinary Fundamentals |
| 2026-03-09 | +0.2% | news | Seeking Alpha | TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX) - Seeking Alpha |
| 2026-03-09 | +0.2% | analyst | Seeking Alpha | TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX) - Seeking Alpha |
| 2023-05-26 | +0.1% | legal | SEC EDGAR | TMDX 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-03-15 | -0.0% | news | Yahoo Finance | Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? - Yahoo Finance |
| 2024-01-29 | +0.0% | legal | SEC EDGAR | TMDX 8-K: 2.01 (SEC Filing) |
| 2026-04-26 | — | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Has $11.25 Million Stock Position in TransMedics Group, Inc. $TMDX - MarketBeat |
| 2026-04-26 | — | news | simplywall.st | Is It Time To Revisit TransMedics Group (TMDX) After Its Strong Three Year Run? - simplywall.st |
| 2026-04-24 | — | news | Insider Monkey | Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? |
| 2026-04-24 | — | news | Seeking Alpha | TransMedics: Revolutionizing The Organ Transplant Market While Trading At A Discount |
| 2026-04-24 | — | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-04-24 | — | news | ChartMill | TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill |
| 2026-04-24 | — | news | Insider Monkey | Is TransMedics Group, Inc. (TMDX) A Good Stock To Buy Now? - Insider Monkey |
| 2026-04-24 | — | news | Sahm | Is TransMedics’ New CHOPS Trial Control Device Reshaping The Investment Case For TransMedics Group (TMDX)? - Sahm |